John Ripple

John Ripple has held a variety of roles in the biotechnology industry since 2013. John started as the CEO of Exonics Therapeutics in 2017, and then became an Entrepreneur in Residence at Mass General Brigham Ventures the same year. In 2020, they became the Co-Founder of Mark Therapeutics Inc., and also took on the roles of Independent Director at BioEntre LLC and Lucy Therapeutics. In 2021, they became an Independent Director at Brave Bio, and a Strategic Advisor at MarvelBiome Inc. Currently, John is the Executive Chair at Praesidia Biotherapeutics, and the Owner of Ripple Biotech LLC.

John Ripple attended Bucknell University, where they earned a BS in Mechanical Engineering. John then went on to Harvard Business School, where they earned an MBA in General Management.